MDxHealth End Period Cash Flow from 2010 to 2025

MDXH Stock  USD 1.93  0.13  7.22%   
MDxHealth's End Period Cash Flow is increasing with slightly volatile movements from year to year. End Period Cash Flow is estimated to finish at about 27.4 M this year. For the period between 2010 and 2025, MDxHealth, End Period Cash Flow quarterly trend regression had mean deviation of  8,072,323 and range of 58.2 M. View All Fundamentals
 
End Period Cash Flow  
First Reported
2004-03-31
Previous Quarter
21.3 M
Current Value
49.3 M
Quarterly Volatility
11.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MDxHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MDxHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 6.7 M or Selling General Administrative of 27.8 M, as well as many indicators such as Price To Sales Ratio of 1.59, Dividend Yield of 0.0 or PTB Ratio of 13.38. MDxHealth financial statements analysis is a perfect complement when working with MDxHealth Valuation or Volatility modules.
  
Check out the analysis of MDxHealth Correlation against competitors.

Latest MDxHealth's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of MDxHealth SA ADR over the last few years. It is MDxHealth's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MDxHealth's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
22.116.058.515.522.425.727.4-28%267%-73%44%15%7%100%
       Timeline  

MDxHealth End Period Cash Flow Regression Statistics

Arithmetic Mean22,934,144
Geometric Mean17,395,801
Coefficient Of Variation53.34
Mean Deviation8,072,323
Median22,380,000
Standard Deviation12,232,849
Sample Variance149.6T
Range58.2M
R-Value0.42
Mean Square Error132.4T
R-Squared0.17
Significance0.11
Slope1,071,808
Total Sum of Squares2244.6T

MDxHealth End Period Cash Flow History

202527.4 M
202425.7 M
202322.4 M
202215.5 M
202158.5 M
202016 M
201922.1 M

About MDxHealth Financial Statements

Investors use fundamental indicators, such as MDxHealth's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although MDxHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
End Period Cash Flow25.7 M27.4 M

Currently Active Assets on Macroaxis

When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:
Check out the analysis of MDxHealth Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.53)
Revenue Per Share
3.099
Quarterly Revenue Growth
0.205
Return On Assets
(0.11)
Return On Equity
(2.41)
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…